About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in Philadelphia | 174 Studies

Clinical Trials DepressionPhiladelphia

Depression Clinical Trials in Philadelphia

Find 174 clinical trials for depression near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Depression trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 174 trials

CompletedA Study in Depression and Associated Painful Physical SymptomsThe purpose of this study is to find out if 60 mg of duloxetine given once a day by mouth for 8 weeks to patients diagnosed with major depressive disorder, who also report…NCT01070329·Sherman Oaks, California and 33 others

Depression Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedSafety, Efficacy, and Tolerability of Vilazodone in Major Depressive DisorderThe purpose of this study was to further characterize the efficacy, safety, and tolerability of a single fixed dose level of vilazodone compared to placebo in patients with major…NCT01473394·Beverly Hills, California and 13 others

CompletedProgressing TAAR-1, Dopamine, and Norepinephrine in Depression Using SolriamfetolPARADIGM (Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to…NCT06360419·Little Rock, Arkansas and 39 others

CompletedStudy Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive DisorderThe primary purpose of this study is to evaluate the efficacy and safety of two doses of DVS SR (50 and 100 mg/day) in the treatment of adults with Major Depressive Disorder.NCT00384033·Beverly Hills, California and 21 others

TerminatedProof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant DepressionThis study is looking at the efficacy, rapidity, safety, and tolerability of two doses of oral CERC-501 for treating patients with treatment resistant depression who are taking an…NCT01913535·Chicago, Illinois and 3 others

CompletedWellbutrin XL, Major Depressive Disorder and Breast Cancer* To evaluate the efficacy of bupropion extended release (Wellbutrin XL™) in the treatment of Major Depressive Disorder in women with breast cancer.NCT00234195·Philadelphia, Pennsylvania

CompletedA Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.The purpose of this study was to demonstrate efficacy, safety and clinical benefit of Trazodone Contramid® OAD (Once A Day) in the treatment of Unipolar Major Depressive Disorder…NCT00775203·Birmingham, Alabama and 35 others

TerminatedEfficacy and Safety Study of ABT-436 in Major Depressive DisorderThe purpose is to study the efficacy and safety of ABT-436 in Major Depressive Disorder.NCT01741142·Little Rock, Arkansas and 17 others

CompletedPhase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive DisorderThe purpose of this study is to assess the safety and tolerability of ascending multiple oral doses of brexpiprazole as adjunctive therapy in the treatment of elderly subjects…NCT01670279·Kissimmee, Florida and 3 others

CompletedSafety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder.NCT00969150·Scottsdale, Arizona and 24 others

Not yet recruitingIndividualized fMRI-guided TMS for DepressionThe goal of this clinical trial is to learn how transcranial magnetic stimulation (TMS) affects brain circuits involving the subgenual anterior cingulate cortex (sgACC) in adults…NCT07804459·Philadelphia, Pennsylvania

CompletedPRIME Care (PRecision Medicine In MEntal Health Care)The focus of this application is on the impact of providing depressed Veterans and their providers with the results of pharmacogenetic (PGx) testing for psychotropic medications.NCT03170362·North Little Rock, Arkansas and 23 others

CompletedAn 8 Week Study Of Depression In Adults Diagnosed With Major Depressive DisorderA Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)NCT00057213·Peoria, Arizona and 20 others

CompletedMini Theta Burst TMS in MDD PatientsThis is not a treatment study.NCT04014959·Philadelphia, Pennsylvania

CompletedA Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive DisorderTo evaluate the efficacy and safety of AXS-05 relative to bupropion in subjects with treatment resistant major depressive disorder (MDD).NCT02741791·Phoenix, Arizona and 73 others

CompletedA Study in the Treatment of Children and Adolescents With Major Depressive DisorderThe purpose of this study is to assess whether duloxetine is superior to placebo in the treatment of children and adolescents with major depressive disorder (MDD)NCT00849693·Birmingham, Alabama and 55 others

CompletedA Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive DisorderThis six-week study will evaluate the efficacy, safety and tolerability of GSK561679 compared to placebo in female subjects with major depressive disorderNCT00733980·Cerritos, California and 17 others

CompletedSafety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in adolescent outpatients (12-17) with major depressive disorder.NCT01878292·Imperial, California and 51 others

CompletedA Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 StudyThis study will evaluate the efficacy and safety of ALKS 5461.NCT02158546·Little Rock, Arkansas and 57 others

CompletedA Safety, Efficacy and Tolerability Study of SEP-225289To determine the safety, efficacy and tolerability of SEP-225289 in subjects with Major Depressive DisorderNCT00584974·Little Rock, Arkansas and 50 others

PreviousPage 3 of 9Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia